OCBCO
VRTX icon

Oversea-Chinese Banking Corp (OCBC)’s Vertex Pharmaceuticals VRTX Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Hold
922
– – 0.01% 320
2026
Q1 		$412K Buy
+922
New +$430K 0.01% 290
2025
Q1 		– Sell
-1,233
Closed -$497K – 437
2024
Q4 		$497K Buy
+1,233
New +$572K 0.01% 283

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s VRTX Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 922 shares worth $458K. The position accounts for 0.01% of the portfolio, ranked #320.

Oversea-Chinese Banking Corp (OCBC) first reported a position in VRTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $497K in Q4 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 922 shares of Vertex Pharmaceuticals worth $458K as of Q2 2026.
  • Oversea-Chinese Banking Corp (OCBC) left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.01% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #320 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Vertex Pharmaceuticals position peaked at $497K in Q4 2024.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.